| Literature DB >> 27492089 |
Malvin Torsvik1, Lise Tuset Gustad2,3, Arne Mehl2,4,5, Inger Lise Bangstad2, Liv Jorun Vinje2, Jan Kristian Damås4,6,7, Erik Solligård4,8,9.
Abstract
BACKGROUND: Systemic inflammatory response syndrome (SIRS) and sepsis are now frequently identified by observations of vital signs and detection of organ failure during triage in the emergency room. However, there is less focus on the effect on patient outcome with better observation and treatment at the ward level.Entities:
Keywords: Adherence; In-hospital; Sepsis; Survival; Systemic inflammatory response syndrome
Mesh:
Year: 2016 PMID: 27492089 PMCID: PMC4974789 DOI: 10.1186/s13054-016-1423-1
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Fig. 1Systemic inflammatory response syndrome (SIRS) and organ failure triage (SOF-Triage), which should be used for all inpatients with suspected infection, and clinical indication for monitoring. GCS Glasgow coma scale
Baseline characteristics at the time of drawing the first positive blood culture in the pre-intervention and post-intervention group (n = 881)
| Pre-intervention | Post intervention | ||
|---|---|---|---|
| (n = 472) | (n = 409) | ||
| Variables | Number (%) | Number (%) |
|
| Age | 0.340 | ||
| < 65 years | 147 (31.1) | 127 (31.1) | |
| 65– ≤ 80 years | 150 (31.8) | 147 (35.9) | |
| > 80 years | 175 (37.1) | 135 (33.0) | |
| Female | 232 (49.2) | 218 (53.3) | 0.219 |
| Place of acquisition | 0.201 | ||
| Community-acquired | 216 (45.8) | 164 (40.1) | |
| Healthcare-acquired | 195 (41.3) | 192 (46.9) | |
| Hospital-acquired | 61 (12.9) | 53 (13.0) | |
| Functional status | <0.001 | ||
| Independent | 269 (57.2) | 284 (69.4) | |
| Partly independent | 139 (29.6) | 72 (17.6) | |
| Dependent | 62 (13.2) | 53 (13.0) | |
| Charlson Comorbidity Index | 0.624 | ||
| 0 | 123 (26.1) | 95 (23.2) | |
| 1–2 | 186 (39.4) | 167 (40.8) | |
| ≥ 3 | 163 (34.5) | 147 (36.0) | |
| Infection severity | <0.001 | ||
| BSI without sepsis | 21 (4.4) | 2 (0.5) | |
| Sepsis | 352 (74.6) | 274 (67.0) | |
| Severe sepsis | 90 (19.1) | 123 (30.1) | |
| Septic shock | 9 (1.9) | 10 (2.4) | |
| SOFA score >2 in any organ | 97 (20.6) | 132 (32.3) | |
| Infection focus | 0.370 | ||
| Lungs | 73 (15.5) | 59 (14.4) | |
| Urinary tract | 189 (40.0) | 183 (44.8) | |
| Other and unknown | 210 (44.5) | 167 (40.8) | |
| Bloodstream infection (BSI) categories | 0.741 | ||
| Gram-negative BSI | 263 (55.7) | 232 (56.7) | |
| Gram-positive BSI | 178 (37.7) | 146 (35.7) | |
| Mixed microbial | 31 (6.6) | 31 (7.6) | |
| Antibiotic before admission (yes) | 64 (13.6) | 71 (17.4) | 0.118 |
| Appropriate antibiotic therapy within 24 h | 402 (85.2) | 356 (87.0) | 0.424 |
| Immunosuppressant use (yes) | 69 (14.6) | 73 (17.9) | 0.194 |
SOFA severe organ failure (score >2 in any organ using the Sequential Organ Failure Assessment) at the time of diagnosis, BSI bloodstream infection
Fig. 2Nurses’ adherence to guidelines for each observation of vital signs (temperature, heart rate or respiratory frequency) during the 24 hours after drawing the first positive blood culture from patients with bloodstream infection (n = 881). Poor observation = 0–1 observation, some observations = 2–4 observations, and good observation = ≥5 observations. The post-intervention group had better observations of all vital signs in patients both with and without organ failure (χ2 test: p ≤ 0.002 for all vital signs)
Hospital inpatients’ odds of surviving 7 and 30 days after the time of drawing the first positive blood culture in the post-intervention group compared to the pre-intervention group (reference group) (n = 881)
| Model 1 | Model 2 | Model 3 | Model 4 | |
|---|---|---|---|---|
| OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | |
| Survival at 7 days | 1.4 (0.7, 2.7) | 1.4 (0.7, 2.7) | 1.3 (0.7, 2.7) | 1.7 (0.8, 3.4) |
| Survival at 30 days | 1.9 (1.2, 3.0) | 1.9 (1.2, 3.0) | 1.8 (1.1, 2.9) | 2.7 (1.6, 4.6) |
Model 1: unadjusted model. Model 2: adjusted for age and sex. Model 3: Model 2 + functional status and Charlson Comorbidity Index. Model 4: Model 3 + dichotomized Sequential Organ Failure Assessment score